Announcements Trials
Browse Landscape

Phase

Phase 2 203Phase 1 96Phase 1/2 66Phase 3 18Phase NA 11Phase EARLY_PHASE1 5Phase 4 5Phase 2/3 5

Status

Unknown 1Terminated 1Not yet recruiting 1Enrolling by invitation 1Completed 1

Sponsor Class

INDUSTRY 11OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Genitourinary 2Tumor-Agnostic 1Plasma cell 1Other hematologic neoplasm 1Lymphoid 1Gastrointestinal 1Dermatologic 1

Conditions

Carcinoma, Renal Cell 2Waldenstrom Macroglobulinemia 1Skin Neoplasms 1Neoplasms, Plasma Cell 1Neoplasms 1Lymphoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Kidney Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Dexamethasone 49Metformin 47Cyclophosphamide 42Saline Solution 38Cytarabine 34Sodium Chloride 32Bupivacaine 31Vincristine 27Cisplatin 26Propofol 25Methotrexate 25Letrozole 24Fluorouracil 24Dexmedetomidine 24Doxorubicin 23Fentanyl 22Carboplatin 22Etoposide 19Rituximab 18Morphine 18Bevacizumab 18Acetaminophen 18Lidocaine 17Granulocyte Colony-Stimulating Factor 17Prednisone 16Mercaptopurine 16Docetaxel 16Clomiphene 16Sevoflurane 15Ropivacaine 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 4 × OTHER × Everolimus × Clear all
NCT07426484 2026-02-23

Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy

Dana-Farber Cancer Institute

Phase 4 Not yet recruiting
80 enrolled
DermatologicLymphoidOther hematologic neoplasmPlasma cell

Lymphoma, Waldenstrom Macroglobulinemia, Skin Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Neoplasms, Plasma Cell

NCT02081755 2026-01-27

Safety and Efficacy of Everolimus Treatment in Liver Transplantation for Liver Cancer

Baylor Research Institute

Phase 4 Enrolling by invitation
336 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT02338570 2018-02-05

ORCHIDEE

Mario Negri Institute for Pharmacological Research

Phase 4 Terminated
31 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT02056587 2014-02-06

Everolimus in Patients With Metastatic Renal Cell Carcinoma Following Progression on Prior Bevacizumab Treatment

Kidney Cancer Research Bureau

Phase 4 Completed
37 enrolled
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00903188 2009-05-18

CISTCERT

University Hospital, Antwerp

Phase 4 Unknown
152 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡